Perinatal mortality in twins, Australia, 1973-1980: II. Maternal age, lethal congenital malformations and sex

J D Doherty1

  • 1Medical Service, Food and Agriculture Organization of the United Nations, Rome, Italy.

Insights

Maternal age influences twin perinatal mortality, with rates decreasing as mothers get older. Congenital malformations also contributed less to twin deaths in older mothers.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Epidemiology
  • Reproductive Health

Background:

  • Perinatal mortality in twins presents unique challenges compared to singletons.
  • Maternal age is a known factor influencing pregnancy outcomes.
  • Congenital malformations are a significant cause of perinatal loss.

Purpose of the Study:

  • To investigate the relationship between maternal age and perinatal mortality in twins.
  • To examine the impact of congenital malformations on twin perinatal deaths.
  • To analyze trends in twin perinatal mortality in Australia between 1973 and 1980.

Main Methods:

  • Retrospective analysis of Australian twin births from 1973-1980.
  • Stratification of perinatal mortality rates by maternal age groups.
  • Comparison of mortality rates based on the presence of congenital malformations.

Main Results:

  • Twin perinatal mortality rates declined with increasing maternal age.
  • Teenage mothers had the highest twin perinatal mortality rate (127.15/1,000).
  • Mortality associated with congenital malformations decreased with maternal age up to 35 years.

Conclusions:

  • Advancing maternal age is associated with reduced perinatal mortality in twins.
  • Congenital malformations play a lesser role in perinatal mortality for older mothers.
  • Findings highlight the importance of maternal age in twin pregnancy management.

Related Concept Videos

Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Sex Linked Disorders01:43

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...